Ixico (IXI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 8.13p
   
  • Change Today:
      0.000p
  • 52 Week High: 20.30
  • 52 Week Low: 7.25
  • Currency: UK Pounds
  • Shares Issued: 48.35m
  • Volume: 0
  • Market Cap: £3.93m

ShareCast News

Ixico confident as full-year revenue, earnings d... 06-Aug-2021 ShareCast
Ixico H1 revenues grow despite Covid-19 impacts ... 26-Apr-2021 ShareCast
Ixico strikes collaboration deal with Microsoft 15-Mar-2021 ShareCast
Ixico selected for Alzheimer's clinical trial 10-Mar-2021 ShareCast
Ixico awarded ?3.4m contract by existing client 24-Dec-2020 ShareCast
Ixico to provide neuroimaging solutions to unnam... 08-Dec-2020 ShareCast
Ixico executes contract for Huntington's disease... 27-Nov-2020 ShareCast
Ixico wins new contracts in Alzheimer's clinical... 03-Nov-2020 ShareCast
Ixico secures two Huntington's disease clinical ... 22-Oct-2020 ShareCast
Ixico FY revenues grow by more than a quarter 19-Oct-2020 ShareCast
Ixico enters deal with NUY Langone Health for dr... 16-Oct-2020 ShareCast
Ixico joins Friedreich's Ataxia research consort... 24-Sep-2020 ShareCast
Ixico joins Friedreich's Ataxia research consort... 24-Sep-2020 ShareCast
Ixico selected to support Alzheimer's trial 21-Sep-2020 ShareCast
Ixico FY revenues, underlying earnings ahead of ... 24-Aug-2020 ShareCast
Ixico sees only 'modest' impact on trading from ... 24-Jun-2020 ShareCast
Ixico in 'robust' position to handle short-term ... 20-Apr-2020 ShareCast
Ixico inks ?10.5m contract, trading impacted by ... 14-Apr-2020 ShareCast
Ixico joins Alzheimer's disease research initiat... 03-Feb-2020 ShareCast
Director dealings: Ixico CEO ups stake 23-Jan-2020 ShareCast
Ixico announces extensions to two studies 23-Dec-2019 ShareCast
Ixico secures three new contracts, appoints chie... 28-Oct-2019 ShareCast
Ixico flags better-than-expected performance for... 15-Oct-2019 ShareCast
IXICO sees full-year results 'materially ahead' ... 19-Aug-2019 ShareCast
Ixico scores two new biopharmaceutical client co... 09-Aug-2019 ShareCast
Ixico revenues on track to meet full-year market... 25-Apr-2019 ShareCast
Ixico signs on two new biopharmaceutical clients 24-Apr-2019 ShareCast
Ixico to assist late phase Huntington's disease ... 05-Mar-2019 ShareCast
Ixico appoints Grant Nash as next CFO 07-Feb-2019 ShareCast
Ixico jumps as new contract wins help to slash l... 04-Dec-2018 ShareCast
New contract wins of £15m spark revenue growth a... 15-Oct-2018 ShareCast
Ixico surges following contract win with 'top te... 11-Sep-2018 ShareCast
IXICO agrees upwards change to Alzheimer's contr... 30-Aug-2018 ShareCast
IXICO says full year will be ahead of market exp... 21-Aug-2018 ShareCast
IXICO expands contract with top 10 pharmaceutica... 13-Aug-2018 ShareCast
Ixico lands £1m contract with top ten pharmaceut... 14-May-2018 ShareCast
Ixico wins expansions to two clinical trial cont... 10-May-2018 ShareCast
Ixico proposes £5.5m placing to accelerate comme... 03-May-2018 ShareCast
IXICO wins new contract worth $2.7m with global ... 30-Jan-2018 ShareCast
IXICO announces new contract with leading biopha... 16-Nov-2017 ShareCast
IXICO signs innovative activity sensor agreement 04-Oct-2017 ShareCast
IXICO signs new contract for imaging services 28-Sep-2017 ShareCast
IXICO wins £1.2m contract with biopharmaceutical... 25-Sep-2017 ShareCast
IXICO signs extension to largest existing contract 05-Sep-2017 ShareCast
IXICO contracted for Alzheimer's vaccine trial 05-Jul-2017 ShareCast
IXICO reduces FY loss 22-May-2017 ShareCast
Ixico wins $1.5m contract for neurodegenerative ... 13-Mar-2017 ShareCast
IXICO to show off experimental tech to global ph... 10-Mar-2017 ShareCast
Giulio Cerroni appointed CEO of IXICO 17-Jan-2017 ShareCast
Ixico joins European syndicate to collect data o... 16-Nov-2016 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ixico Market Data

Currency UK Pounds
Share Price 8.13p
Change Today 0.000p
% Change 0.00 %
52 Week High 20.30
52 Week Low 7.25
Volume 0
Shares Issued 48.35m
Market Cap £3.93m

Ixico Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.29% above the market average38.29% above the market average38.29% above the market average38.29% above the market average38.29% above the market average
80.39% above the sector average80.39% above the sector average80.39% above the sector average80.39% above the sector average80.39% above the sector average
Price Trend
87.21% below the market average87.21% below the market average87.21% below the market average87.21% below the market average87.21% below the market average
49.09% below the sector average49.09% below the sector average49.09% below the sector average49.09% below the sector average49.09% below the sector average
Income Not Available
Growth
87.35% below the market average87.35% below the market average87.35% below the market average87.35% below the market average87.35% below the market average
77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average

Ixico Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Ixico Key Personnel

CEO Giulio Cerroni

Top of Page